| |  Biosynthetic Human Insulin + JDRF | 5 articles |
| Page 1 of 1 | Previous | Next | SCOTT'S WEB LOG APRIL 18, 2011 [Biosynthetic Human Insulin, JDRF] Medtronic Visit Update Medtronic (Minimed) Diabetes is pretty much the market share leader in the insulin pump space, as the first-to-market for commercialized insulin pumps (with about 70% share of the U.S. But the insulin pump market is evolving. Growing Market for Insulin Pumps Lures New Competition, Innovation Medtronic's insulin pump competiton includes longtime rival Roche which began as a Swiss company formerly known as Disetronic back in 1984 and entered the U.S. | | |
| SCOTT'S WEB LOG JULY 14, 2008 [Biosynthetic Human Insulin, JDRF] New Research Clarifies Distinction Between Different Types of Diabetes Some authors even argued that type 1 and type 2 diabetes are actually the same disorder of insulin resistance, set against different genetic backgrounds (unfortunately for them, their so-called " Accelerator Hypothesis " had numerous shortcomings, particularly the fact that relatively few of the children in their own research sample were overweight, the insulin requirements of lean patients were statistically much lower than those who were overweight, as well as many other shortcomings). | SCOTT'S WEB LOG JULY 14, 2008 [Biosynthetic Human Insulin, JDRF] New Research Clarifies Distinction Between Different Types of Diabetes Some authors even argued that type 1 and type 2 diabetes are actually the same disorder of insulin resistance, set against different genetic backgrounds (unfortunately for them, their so-called " Accelerator Hypothesis " had numerous shortcomings, particularly the fact that relatively few of the children in their own research sample were overweight, the insulin requirements of lean patients were statistically much lower than those who were overweight, as well as many other shortcomings). | | |
| |
|
| |
Let's personalize your content